(Q34580335)

3 August 2017

1 reference

title

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states (English)

1 reference

3 August 2017

2

Chrousos GP

1 reference

3 August 2017

Gold PW

1

1 reference

PubMed ID

11920153

3 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

254-275

1 reference

3 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001032

3 August 2017

0 references

cites work

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Natural history and preventative treatment of recurrent mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Minor and major depression and the risk of death in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Bone mineral density in women with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Stressful life events, genetic liability, and onset of an episode of major depression in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The lifetime history of major depression in women. Reliability of diagnosis and heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Reversed neurovegetative symptoms of depression: a community study of Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The validity of major depression with atypical features based on a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Emotion: clues from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Mechanisms of emotional arousal and lasting declarative memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Influence of Corticotropin-Releasing Factor on Reproductive Functions in the Rat*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Effects of corticotropin releasing hormone on appetitive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Through the looking glass: differential noradenergic modulation of prefrontal cortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The prefrontal cortex--an update: time is of the essence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Storage and executive processes in the frontal lobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The biology of being frazzled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Extinction of emotional learning: contribution of medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Effect of ganglion blockade on cerebrospinal fluid norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The peripheral kinetics of norepinephrine in depressive illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Resting Plasma Catecholamine Concentrations in Patients With Depression and Anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Role of biogenic amines in certain pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The neurobiology of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

21 January 2018

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Subgenual prefrontal cortex abnormalities in mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Effect of dexamethasone on proliferating osteoblasts: inhibition of prostaglandin E2 synthesis, DNA synthesis, and alterations in actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Functional neuroimaging studies of depression: the anatomy of melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Anaclitic depression in an infant raised in an institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Extended life-span and stress resistance in the Drosophila mutant methuselah

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

Three-year outcomes for maintenance therapies in recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

The clinical implications of corticotropin-releasing hormone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Suicide and Primary Affective Disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: the development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Role of the locus coeruleus in emotional activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Memory networks in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

The prefrontal cortex and its relation to behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Transient Depressive Relapse Induced by Catecholamine Depletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Indices of noradrenergic output in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Cerebrospinal fluid adrenaline and noradrenaline in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

3-Methoxy-4-hydroxyphenylglycol in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

High plasma norepinephrine levels in patients with major affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Depressive symptom patterns and urinary MHPG excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

MHPG excretion in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

1 reference

7 January 2021

The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

A functional anatomical study of unipolar depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Changes in regional cerebral blood flow on recovery from depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Atypical depressive symptoms possibly predict responsiveness to phototherapy in seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

The cytokine-HPA axis feed-back circuit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Can the chronic fatigue syndrome be defined by distinct clinical features?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001032

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001032

1 reference

3 August 2017

1 reference

PubMed ID

11920153